Susan G. Macdonald

Susan Macdonald is an experienced professional in the life science industry, currently serving as the Vice President of R&D Strategy and Program Management at Incendia Therapeutics. With a background in project management and strategic development, Susan has held various leadership roles in companies such as Hubble Therapeutics, Aldeyra Therapeutics, and Alexion Pharmaceuticals. Their expertise also extends to consulting as the Principal and Founder of Sixteen Hands Biopharma Consulting. Susan's academic background includes a Ph.D. in Cellular and Molecular Physiology from UMass Chan Medical School and a B.S. in Biology from Hobart and William Smith Colleges.